Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Bleomycin for Low-Flow Vascular Malformations
NCT07728825Phase 4Completed
- Sponsor
- University of Anbar
- Start
- Aug 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 4 trial of bleomycin in vascular malformation, sponsored by University of Anbar. Started Aug 2025; status: completed.
02
Drugs
bleomycin
03
Conditions
vascular malformation
Beyond the preview
Go deeper on NCT07728825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07728825.